Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2010
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1485093B1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/03/2010EP1405853B1 Isoxazoline derivatives and herbicides
11/03/2010EP1220838B1 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds
11/03/2010CN101878205A Phenyl-oxetanyl-derivatives
11/03/2010CN101878199A 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
11/03/2010CN101875655A Aminobenzoic acid derivative as well as preparation method and application thereof
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/03/2010CN101328155B Oxazolidine derivates, preparation and application thereof
11/03/2010CN101184487B Bicyclic pyrazole compounds as antibacterial agents
11/02/2010US7825260 (R)-2-amino-4-(2-benzo[1,3]dioxol-5-yl-benzoxazol-5-yl)-2-methyl-butan-1-ol; for the treatment or prevention of allo- or xenograft acute or chronic rejection or inflammatory or autoimmune disorders, or as a chemotherapeutic agent, e.g a malignant cell anti-proliferative agent
11/02/2010US7825242 Immunosuppressants; autoimmune diseases; antiinflammatory agents;antiarthritic agents; aids
11/02/2010US7825155 Oxindole derivative as feeding control agent
11/02/2010US7825152 Organic compounds and their uses
11/02/2010US7825147 Enzyme inhibitors of phosphodiesterases for treatment of AIDS, asthma, arthritis, bronchitis and other disorders
11/02/2010US7825142 imidazole-based compounds such as (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol, used for the treatment and prevention of inflammatory and autoimmune diseases
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825128 such as N-(ethoxycarbonyl)-S-(4-{[4-{[(R)-2-hydroxy-1-methylethyl]amino}-5-(2-thienyl)pyrimidine-2-yl]amino}phenyl)-S-methylsulfoximide, used for the treatment of breast cancer and rheumatoid arthritis
11/02/2010US7825113 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2436361C Angiotensin ii antagonistic compound for use as analgesic and antiinflammatory agent
11/02/2010CA2413971C Heterocyclic hydrazones as novel anti-cancer agents
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010124121A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
10/28/2010WO2010124119A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124108A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010123451A1 Sulphide bridged derivatives as modulators of mglur5
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123006A1 Pyrrolidine compound
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122151A1 3 -azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010WO2010122038A1 Inhibitors of bruton's tyrosine kinase
10/28/2010WO2010121963A1 Resorcinol derivatives as hsp90 inhibitors
10/28/2010WO2010121918A1 Proline derivatives as cathepsin inhibitors
10/28/2010WO2010093849A3 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
10/28/2010WO2010077882A3 Antagonists of lysophosphatidic acid receptors
10/28/2010WO2009140089A8 Sulfone compounds which modulate the cb2 receptor
10/28/2010WO2009118765A3 Novel monoamine re-uptake inhibitor
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100273832 Insecticidal compounds
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
10/28/2010US20100273805 Sulphide bridged derivatives as modulators of mglur5 733
10/28/2010US20100273799 Small molecule inhibitors of mdm2 and the uses thereof
10/28/2010US20100273798 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273796 2-benzylpyridazinone derivatives as met kinase inhibitors
10/28/2010US20100273795 Arylsulfonamide ccr3 antagonists
10/28/2010US20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity
10/28/2010US20100273793 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS c-MET INHIBITORS
10/28/2010US20100273790 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273789 Aminoacyl prodrugs
10/28/2010US20100273786 Tetrahydro-imidaz0[1,5-a]pyrazine derivatives, preparation process and medicinal use thereof
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273780 Substituted 8-heteroaryl xanthines
10/28/2010US20100273771 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
10/28/2010US20100273770 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases
10/28/2010US20100273768 Inhibitors of Bruton's Tyrosine Kinase
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010US20100272683 Heterocyclylaminoalkyl substituted benzimidazoles
10/28/2010CA2759714A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759713A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759160A1 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2758210A1 Proline derivatives as cathepsin inhibitors
10/28/2010CA2748414A1 Inhibitors of bruton's tyrosine kinase
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2242753A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof
10/27/2010EP2242743A1 Aminopyrazole derivatives
10/27/2010EP2242742A2 Organic compounds
10/27/2010EP2242741A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
10/27/2010EP1891057B1 Azabicyclo[3.1.0]hexane derivaives as dopamin d3 receptor modulators
10/27/2010EP1539710B1 Heterocyclic derivatives
10/27/2010CN1898231B Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
10/27/2010CN1878762B Morpholine derivatives as norepinephrine reuptake inhibitors
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874028A 2-aza-bicyclo[3.3.0]octane derivatives
10/27/2010CN101870693A Bismaleimide containing 1,3,4-oxadiazole structure and preparation method thereof
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/27/2010CN101870677A 5-arylmethoxy radical phenyl pyrazol compound and preparation method thereof
10/26/2010USRE41895 Epothilone derivatives
10/26/2010US7820838 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
10/26/2010US7820823 Dual action antibiotics
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820818 Inhibitors of cathepsin K; inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors; 4-Cyclopentylamino-5-(4-phenyl-but-1-ynyl)-pyrimidine-2-carbonitrile; 5-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-prop-1-ynyl]-4-(2,2-dimethyl-propylamino)-pyrimidine-2-carbonitrile
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820705 Compounds and compositions as PPAR modulators
10/26/2010US7820682 3-{[(3R)-1-(3,5-dimethoxy-4-methylbenzoyl)-5-(2-phenylethyl)-3-pyrrolidinyl]oxy}benzoic acid methyl ester; treatment of urinary system disease; anticarcinogenic agent, antiarthritic agent, treats proliferative disease, inflammation/immune system disease, Sjogren*s syndrome, brain-related disease
10/26/2010US7820680 HIV integrase inhibitors
10/26/2010US7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
10/26/2010US7820674 Especially 1-(5-((R)-2-Amino-1-phenylpropan-2-yl)-1,3,4-oxadiazol-2-yl)methyl)-4-butylpiperazine-2,3-dione or derivatives; amyloid precursor protein-cleaving enzyme
10/26/2010US7820661 prostaglandin EP2 receptor agonists for treating baldness, glaucoma, post-surgical and post-laser trabeculectomy ocular hypertensive episodes, inflammatory bowel disease, and as presurgical adjuncts
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820659 (R)-3-(3,5-Dichloro-4'-morpholin-4-yl-biphenyl-4-ylmethyl)-1-(4,5,6,7-tetrahydro-1H-benzoimidazol-5-yl)-pyrrolidin-2-one for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 647